期刊文献+

IL-1α、Bax、Bcl-2等基因mRNA在帕金森病小鼠模型中的表达 被引量:1

Expression of Cytokines and Apoptotic Genes in the Murine Model of Parkinson Disease
下载PDF
导出
摘要 目的 :探讨细胞因子IL 1α和IL 10与凋亡相关基因Bcl 2家族中Bax和Bcl 2在 1 甲基 4 苯基 1,2 ,3,6 四氢吡啶(MPTP)致C5 7BL6J小鼠帕金森病模型中黑质和纹状体内的表达意义及关系。方法 :利用RT PCR的方法检测对照组 (NS组 )C5 7BL6J小鼠及皮下注射MPTP后第 6天C5 7BL6J小鼠的左右侧脑内黑质、纹状体、下丘脑内的IL 1α ,IL 10 ,Bax和Bcl 2的mRNA的表达。结果 :与对照组相比 ,IL 1αmRNA在帕金森小鼠模型纹状体内表达显著增加 ;除对照组 1只外 ,对照组和MPTP组均未检测到IL 10mRNA的表达 ;BaxmRNA和Bcl 2mRNA在黑质内的表达均显著低于对照组。结论 :黑质和纹状体在MPTP所致的小鼠帕金森病中受累 ,表现为有不同基因的消长。促进炎症发生的细胞因子IL Objective:To study the mRNA expression of cytokines(IL 1α and IL 10)and apoptotic genes(Bax and Bcl 2) in C57BL6J mice after the administration of 1 methyl 4 phenyl 1,2,3,6 tetrahydropyridine(MPTP).Methods:C57BL6J male mice received a single subcutaneous injection of MPTP(40mg/kg).Control group was injected with NS.On the sixth day after injection,the mRNA expression of IL 1α,IL 10,Bax and Bcl 2 in the substantia nigra,striatum and hypothalamus was studied by RT PCR.Results:As compared to the NS group,IL 1α mRNA expression was significantly higher in the striatum of mice injected with MPTP,but not in the substantia nigra and hypothalamus.IL 10 mRNA expression was not detected in any brain structures from both groups.As compared to the NS group,Bax mRNA and Bcl 2 mRNA expression in the substantia nigra,but not in the striatum and hypothalamus,were significantly lower in the MPTP group.Conclusion:The mechanisms of MPTP induced Parkinson disease include both inflammation and apoptosis.The expression of the cytokine(IL 1α) increase in the striatum,but its role is not elucidated yet.Mitochondria pathway of apoptosis in the substantia nigra may be involved in the MPTP induced Parkinson disease.
出处 《汕头大学医学院学报》 2003年第1期5-8,15,共5页 Journal of Shantou University Medical College
基金 中法先进研究计划项目 (PRAB97 0 3 ) 国家自然科学基金资助项目 (3 0 2 712 11) 汕头大学研究与发展基金 (L0 0 0 11)
关键词 IL-1Α BAX BCL-2 基因mRNA 帕金森病 小鼠模型 表达 Parkinson disease C57BL/6J Mice Apoptosis Cytokines N methyl 4 phenyl 1,2,3,6 tetrahydropyridine
  • 相关文献

参考文献19

  • 1Nagastu T. Isoquinoline neurotoxins in the brain and Parkinson's disease[J]. Neurosci Res, 1997, 29:99-111.
  • 2Mochizuki H, Goto K, Moil H et al. Histochemical detection of apoptosis in Parkinson's disease[J]. J Nettrol Sci, 1996,137:120-123.
  • 3Kuhn W, Muller TH. Neuroimmune mechanisms in Parkinson's disease[J]. J Neural Transm, 1995, 46: 229-233.
  • 4Mogi M, Harada M, Narabayashi H et al. Interleukin(IL)-1β, IL-2, IL-4, IL-6 and transplanting growth factor-α levels are elevated in ventricular cerebrospinal fluid in Parkinson's disease[J]. Neurosci Lett, 1995, 193:129-132.
  • 5Muthane U, Ramsay KA, Jiang H et al. Differences in nigra neuron number and sensitivity to 1-methyl-4-phenyl-1, 2, 3,6-tetrahydropyridine in C57BL and CD-1 mice[J]. Exp Neurol, 1994, 126:195-204.
  • 6Anglade P, Vyas S, Javoy AF et al. Apoptosis and autophagy in nigral neurons of patients with Parkinson's disease[J]. Histol Histopathol, 1997, 12:25-31.
  • 7Spooren W, Gentsch C, Wiessner C. Tunel-positive cells in the substantia nigra of C57BL/6 mice after a single bolus of 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine[J]. Neuroscience, 1998, 85:649-651.
  • 8Hassouna L, Wickert H, Ziramermann M et al. Increase in bax expression in substantia nigra following l-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine(MPTP)treatment of mice[J].Neurosci Lett, 1996, 204:85-88.
  • 9Vila M, Jackson LV, Vukosavic S et al. Bax ablation prevents dopaminergic neurodegeneration in the l-methyl-4-phenyl-l, 2, 3, 6-tetrahydropyridine mouse model of Paddnson disease[J]. Proe Nail Aead Sci U. S. A., 2001, 98:2837-2842.
  • 10Yang L, Matthews RT, Schulz JB et al. l-Methyl-4-phenyl-1, 2, 3, 6-tetrahydropyride neurotoxicity is attenuated in mice overexpressing Bcl-2 [J]. J Neurosci, 1998, 18:8145-8152.

同被引文献22

  • 1管小亭,王春雪,龙洁,资深.帕金森病患者外周血TNF-α浓度和IL-6质量浓度的检测及分析[J].首都医科大学学报,2004,25(2):233-235. 被引量:12
  • 2苏闻,陈海波,王新德.帕金森病治疗药物对患者外周血单核细胞分泌细胞因子的影响[J].中华老年医学杂志,2004,23(7):454-456. 被引量:4
  • 3刘洁,周东,唐勇,杨友松.MPTP诱导帕金森病小鼠黑质致密部细胞因子含量变化的研究[J].四川医学,2005,26(5):526-527. 被引量:9
  • 4Blum D, Muller T, Kulm W, et al. Interleukin-1 beta and interleukin-6 are elevated in the cerebrospinal fluid of Alzheimer's and de novo Parkinson's disease patients[J]. Neurosci Lett,1995 ;202:17-20.
  • 5Fcrrari CC, Port Godoy MC, Tarelli R, et al. Progressive neurodegeneration and motor disabilities induced by chronoc expression of IL-beta in the substantia nigra[J]. Neurobiol Dis,2006 ;24( 1 ) :183-93.
  • 6Shen YQ,Hebert G,Su Y,et al. In mice,preduction of plasma IL-1 and IL-6 in response to MPTP is related to behavioral lateralization[J]. Brain Res,2005 ;1045 (1-2) :31-7.
  • 7Mogi M, Harada M, Kondo T, et al. Interleukin-1 beta, interleukin-6, epidermal growth factor and transforming growth factor alpha and elevated in the brain from Parkinson patients[J]. Neurosci Lett,1994;180:147-50.
  • 8Hasegawa Y,Inagaki T,Sawada M ,et al. Impaired cytokine production by peripheral blood mononuclear cells and monocytes/macrophages in Parkinson's disease[J]. Acta Neurol Stand,2000 ; 101 (3) : 159-64.
  • 9Moller JC,Depbedylu C,Kolsch H,et al. Lack of association between the interleukin-1 alpha (-889) polymorphism and early-onset Parkinson' s disease[J]. Neurosci Lett,2004 ;359(3) :195-7.
  • 10McGeer PL, Yasojima K, McGeer EG. Association of interleukin-1 beta polynorphisms with idiopathic Parkinson' s disease[J]. Neurosci Lett, 2002;326( 1 ) :67-9.

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部